Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row. …
Dipexium effected a reverse stock split of its issued and outstanding shares of common stock at a ratio of 1-for-8. The holders of shares of PLx common stock outstanding immediately prior to the merger received, as merger consideration, …
NASDAQ4mon
Protalix BioTherapeutics (NYSEMKT: PLX) is off to an incredibly strong start to the trading session today, and for good reason. The company reported earnings for the first quarter, coming in ahead of expectations on both the top and …
Investors in Protalix BioTherapeutics, Inc. (PLX - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the May 19 th 2017 $1.00 Call had some of the highest implied volatility of …
ZACKS4mon
PLx Pharma Inc. (NASDAQ:PLXP ... Purchase Agreement with certain investors providing for the issuance of 2,646,091 shares of common stock at an offering price per share of $6.875 in a registered direct offering, and also agreed to issue …
Boasting a price of $5.90, PLx Pharma (NASDAQ:PLXP) traded 5.08% higher on the day. With the last stock price …
'Sense8′ Will Return for Two Hour Finale Special After Cancellation Sense8 is returning for a two-hour finale special next year, despite the show's cancellation after two seasons! Co-creator Lana Wachowski announced the news…... [Read …
PLx Pharma and Dipexium Pharmaceuticals have agreed to an all-stock merger, through which Dipexium is issuing approximately 36 million new shares of its common stock to PLx shareholders. Following closure, PLx shareholders …